- Home
- » Tags
- » Lusutrombopag
Top View
- Klasifikacija ATC 2019
- Mulpleta® (Lusutrombopag) Effective 12/01/20
- Nye Legemidler Som Ikke Har Markedsføringstillatelse for Legemidler Oppført På Listen Gjelder Retningslinjens Vilkår Uavhengig Av Indikasjon for Bruken
- Mulpleta® (Lusutrombopag) (Oral) Document Number: IH-0377 Last Review Date: 02/04/2020 Date of Origin: 09/05/2018 Dates Reviewed: 09/2018, 02/2019, 02/2020
- Doptelet Mulpleta Promacta and Tavalisse
- Carecontinuum™ 1199 SEIU Drug List
- Thrombocytopenia and Hemostatic Changes in Acute and Chronic Liver Disease: Pathophysiology, Clinical and Laboratory Features, and Management
- New Drug Evaluation Monograph Template
- New Small Molecule Drugs for Thrombocytopenia: Chemical, Pharmacological, and Therapeutic Use Considerations
- Mandatory Specialty Drug List
- October 2017 a View Into Upcoming Specialty and Traditional Drugs TABLE of CONTENTS
- Final Belgian List
- Southampton Joint Formulary Cumulative Update
- Avatrombopag (Doptelet®), Eltrombopag (Promacta®), Lusutrombopag (Mulpleta®), Fostamatinib (Tavalisse™) EOCCO POLICY
- Universidade De Brasília Faculdade De Ciências Da Saúde
- CVS Caremark® Value Formulary Effective As of 07/01/2021
- Drugs Formulary
- Optumrx Brand Pipeline Forecast
- DRAFT COMPARISON of the WHO ATC CLASSIFICATION & Ephmra
- Supplementary Table 1: List of Drugs and Their Binding Energies to ACE and ACE2
- FORMULARY MARCH 2021 CONTENTS Please Use Ctrl + F Or the Binoculars to Search an Item
- Scientific Programme Friday, 05. July 2019 Registration
- Klasifikacija ATC 2021
- 210923Orig1s000
- April 2018 a View Into Upcoming Specialty and Traditional Drugs TABLE of CONTENTS
- Joint Formulary for Hull and East Riding of Yorkshire
- Meds Entry Watch New Medicines Approved in 2018
- Tenofovir Alafenamide
- 210923Orig1s000
- Lusutrombopag Shionogi
- INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
- 5.01.566 Pharmacotherapy of Thrombocytopenia
- 2019 Medicaid Preapproval Criteria